Markus Ries

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

Atul Mehta, Renato Pietro Ricci, Urs Widmer et al. · European Journal of Clinical Investigation · 2004 · 852 citations · Full text

Life Sciences, Biochemistry, Clinical Sciences +12

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

Atul Mehta, Michael Beck, Perry Elliott et al. · The Lancet · 2009 · 273 citations · Full text

Life Sciences, Pharmacotherapy, Enzymology +5

Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting

Raphael Schiffmann, Markus Ries, Margaret Timmons et al. · Nephrology Dialysis Transplantation · 2005 · 268 citations · Full text

Life Sciences, Biochemistry, Nephrology +14

The Mainz Severity Score Index: a new instrument for quantifying the Anderson–Fabry disease phenotype, and the response of patients to enzyme replacement therapy

Catharina Whybra, Christoph Kampmann, Frank Krummenauer et al. · Clinical Genetics · 2004 · 267 citations

Life Sciences, Clinical Sciences, Enzymology +10

Randomized, controlled trial of miglustat in Gaucher's disease type 3

Raphael Schiffmann, Edmond J. FitzGibbon, Chris Harris et al. · Annals of Neurology · 2008 · 233 citations · Full text

Medicine, Neurology, Pharmacotherapy +14